4
Changes in Ownership
Vir Biotechnology, Inc. Filed Acc 0001209191-21-026392
EVP, Research & CSO acquired 14,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Virgin Herbert EVP, Research & CSO | 2021-04-09 | Option exercise | +14,000 | $1.53 | $21,420 | 88,200 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Virgin Herbert EVP, Research & CSO | 2021-04-09 | Option exercise · Stock Option (Right to Buy) | −14,000 | 323,555 | D: show line 2 in the form |
Loading xslF345X03/doc4.xml…